Maturitas
Volume 55, Issue 3 , Pages 264-269 , 20 October 2006

Endometrial cancer patients and tibolone: A matched case–control study

  • Kwang-Beom Lee

      Affiliations

    • Department of Obstetrics and Gynecology, Gachon Medical School, Inchon, Republic of Korea
    • ,
  • Jong-Min Lee

      Affiliations

    • Department of Obstetrics and Gynecology, Kyunghee University, Seoul, Republic of Korea
    • Corresponding Author InformationCorresponding author. Tel.: +82 11738 3725; fax: +82 2 440 8741.
    • ,
  • Jae-Kwan Lee

      Affiliations

    • Department of Obstetrics and Gynecology, Korea University, Seoul, Republic of Korea
    • ,
  • Chi-Heum Cho

      Affiliations

    • Department of Obstetrics and Gynecology, Keimyung University, Daegu, Republic of Korea

Received 13 December 2005 ,Revised 29 March 2006 ,Accepted 30 March 2006.

References 

  1. 2002 Annual report of the Korea central cancer registry (2002.1-2002.12). Republic of Korea: Korea Central Cancer Registry, Ministry of Health and Welfare; 2003.
  2. Annual report of gynecologic cancer registry program in Korean for 2002 (Jan. 1st, 2002-Dec. 31st, 2002). Kr J Obstet Gynecol 2004; 6:1029-71.
  3. Gitsch G, Hanzal E, Jensen D, Hacker NF. Endometrial cancer in premenopausal women 45 years and younger. Obstet Gynecol. 1995;85:504–508
  4. Chapman JA, DiSaia PJ, Osann K, Roth PD, Gillotte DL, Berman ML. Estrogen replacement in surgical stage I and II endometrial cancer survivors. Am J Obstet Gynecol. 1996;175:1195–1200
  5. American College of Obstetricians Gynecologists . ACOG committee opinion-hormone replacement therapy in women treated for endometrial cancer. Int J Gynaecol Obstet. 2001;73:283–284
  6. Parslov M, Lidegaard O, Klintorp S, et al. Risk factors among young women with endometrial cancer: a Danish case–control study. Am J Obstet Gynecol. 2000;182:23–29
  7. Tran BN, Connell PP, Waggoner S, Rotmensch J, Mundt AJ. Characteristics and outcome of endometrial carcinoma patients age 45 years and younger. Am J Clin Oncol. 2000;23:476–480
  8. Evans-Metcalf ER, Brooks SE, Reale FR, Baker SP. Profile of women 45 years of age and younger with endometrial cancer. Obstet Gynecol. 1998;91:349–354
  9. Feldman BM, Voda A, Gronseth E. The prevalence of hot flash and associated variables among perimenopausal women. Res Nurs Health. 1985;8:261–268
  10. Hreshchyshyn MM, Hopkins A, Zylstra S, Anbar M. Effects of natural menopause, hysterectomy, and oophorectomy on lumbar spine and femoral neck bone densities. Obstet Gynecol. 1988;72:631–638
  11. Centerwall BS. Premenopausal hysterectomy and cardiovascular disease. Am J Obstet Gynecol. 1981;139:58–61
  12. SEER Cancer Statistics Review 1975–2000. (http://seer.cancer.gov/csr/1975_2000).
  13. Creasman WT, Odicino F, Maisonneuve P, et al. Carcinoma of the corpus uteri. J Epidemiol Biostat. 2001;6:47–86
  14. North American Menopause Society (NAMS) 2003. Estrogen and progesterone use in the peri-and postmenopausal women: September 2003 position statement of the North American Menopause Society. Menopause 2003; 10:497–506.
  15. Creasman WT, Henderson D, Hinshaw W, Clarke-Pearson DL. Estrogen replacement therapy in the patient treated for endometrial cancer. Obstet Gynecol. 1986;67:326–330
  16. Lee RB, Burke T, Park RC. Estrogen replacement therapy following treatment for stage I endometrial carcinoma. Gynecol Oncol. 1990;36:189–191
  17. Chapman JA, Disaia PJ, Osann K, Roth PD, Gillotte DL, Berman ML. Estrogen replacement in surgical stage I and II endometrial cancer survivors. Am J Obstet Gynecol. 1996;175:1195–1200
  18. Suriano KA, McHale M, McLaren CE, Li KT, Re A, DiSaia PJ. Estrogen replacement therapy in endometrial cancer patients: a matched control study. Obstet Gynecol. 2001;97:555–560
  19. DiSaia PJ, Brewster WR. Hormone replacement therapy for survivors of breast and endometrial cancer. Curr Oncol Rep. 2002;4:152–158
  20. Kenemans P, Speroff L. Tibolone: clinical recommendations and practical guidelines a report of the International Tibolone Consensus Group. Maturitas. 2005;51:21–28
  21. Baracat EC, Barbosa IC, Giordano MG, et al. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability. Climacteric. 2002;5:60–69
  22. Morris EP, Wilson POG, Robinson J, Rymer JM. Long-term effects of tibolone on the genital tract in postmenopausal women. Br J Obstet Gynaecol. 1999;106:954–959
  23. Davis SR. The effects of tibolone on mood and libido. Menopause. 2002;9:162–170
  24. Egarter Ch , Huber J, Leikermoser R, et al. Tibolone versus conjugated estrogens and sequential progestogen in the treatment of climacteric complaints. Maturitas. 1996;23:35–48
  25. Roux C, Pelissier C, Fechtenbaum J, Loiseau-Peres S, Benhamou CL. Randomized, double-blind, 2-year comparison of tibolone with 17β-estradiol and norethindrone acetate in preventing postmenopausal bone loss. Osteoporos Int. 2002;13:241–248
  26. Lundström E, Christow A, Svane G, et al. Effects of tibolone and a continous combined HRT regimen on mammographic breast density. Am J Obstet Gynecol. 2002;186:717–722
  27. Valdivia I, Campodonico I, Tapia A, et al. Effects of tibolone and continuous combined hormone therapy on mammographic breast density and breast histochemical markers in postmenopausal women. Fertil Steril. 2004;81:617–623
  28. Blok LJ, De Ruiter PE, Kuhne EC, et al. Progestogenic effects of tibolone on human endometrial cancer cells. J Clin Endocrinol Metab. 2003;88:2327–2334
  29. Hanifi-Moghaddam P, Gielen SC, Kloosterboer HJ, et al. Molecular portrait of the progestagenic and estrogenic actions of tibolone: behavior of cellular networks in response to tibolone. J Clin Endocrinol Metab. 2005;90:973–983
  30. Million Women Study Collaborators . Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2005;365:1543–1551

PII: S0378-5122(06)00103-4

doi: 10.1016/j.maturitas.2006.03.012

Maturitas
Volume 55, Issue 3 , Pages 264-269 , 20 October 2006

Article Tools

* Image Usage & Resolution